Page last updated: 2024-10-31

1-(3-trifluoromethylphenyl)piperazine and Obesity

1-(3-trifluoromethylphenyl)piperazine has been researched along with Obesity in 2 studies

1-(3-trifluoromethylphenyl)piperazine: acts as serotonin agonist; structure
1-(3-(trifluoromethyl)phenyl)piperazine : A N-arylpiperazine that is piperazine substituted by a 3-(trifluoromethyl)phenyl group at position 1. A serotonergic agonist used as a recreational drug.

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rouru, J2
Pesonen, U2
Isaksson, K1
Huupponen, R2
Koulu, M2
Hänninen, H1
Seppälä, T1

Other Studies

2 other studies available for 1-(3-trifluoromethylphenyl)piperazine and Obesity

ArticleYear
Effect of chronic treatment with TFMPP, a 5-HT1 receptor agonist, on food intake, weight gain, plasma insulin and neuropeptide mRNA expression in obese Zucker rats.
    European journal of pharmacology, 1993, Apr-06, Volume: 234, Issue:2-3

    Topics: Animals; Autoradiography; Blood Glucose; Corticotropin-Releasing Hormone; Eating; Insulin; Male; Neu

1993
Hypothalamic neurochemistry and feeding behavioral responses to clonidine, an alpha-2-agonist, and to trifluoromethylphenylpiperazine, a putative 5-hydroxytryptamine-1B agonist, in genetically obese Zucker rats.
    Neuroendocrinology, 1990, Volume: 52, Issue:5

    Topics: 5-Hydroxytryptophan; Adrenergic alpha-Agonists; Animals; Aromatic Amino Acid Decarboxylase Inhibitor

1990